Top ▲

Insulin receptor-related receptor

Click here for help

Target not currently curated in GtoImmuPdb

Target id: 1802

Nomenclature: Insulin receptor-related receptor

Abbreviated Name: IRR

Family: Type II RTKs: Insulin receptor family

Contents:

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 1 1297 1q23.1 INSRR insulin receptor related receptor
Mouse 1 1300 3 38.7 cM Insrr insulin receptor-related receptor
Rat 1 1300 2q34 Insrr insulin receptor-related receptor
Previous and Unofficial Names Click here for help
IR-related receptor | Sirr
Database Links Click here for help
Alphafold P14616 (Hs), Q9WTL4 (Mm), Q64716 (Rn)
BRENDA 2.7.10.1
CATH/Gene3D 2.60.40.10, 3.80.20.20
ChEMBL Target CHEMBL5483 (Hs)
Ensembl Gene ENSG00000027644 (Hs), ENSMUSG00000005640 (Mm), ENSRNOG00000057702 (Rn)
Entrez Gene 3645 (Hs), 23920 (Mm), 60663 (Rn)
Human Protein Atlas ENSG00000027644 (Hs)
KEGG Enzyme 2.7.10.1
KEGG Gene hsa:3645 (Hs), mmu:23920 (Mm), rno:60663 (Rn)
OMIM 147671 (Hs)
Pharos P14616 (Hs)
RefSeq Nucleotide NM_014215 (Hs), NM_011832 (Mm), NM_022212 (Rn)
RefSeq Protein NP_055030 (Hs), NP_035962 (Mm), NP_071548 (Rn)
UniProtKB P14616 (Hs), Q9WTL4 (Mm), Q64716 (Rn)
Wikipedia INSRR (Hs)
Enzyme Reaction Click here for help
EC Number: 2.7.10.1

Download all structure-activity data for this target as a CSV file go icon to follow link

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
linsitinib Small molecule or natural product Click here for species-specific activity table Hs Inhibition 7.1 pIC50 4
⤷ pIC50 7.1 (IC50 7.5x10-8 M) [4]
DiscoveRx KINOMEscan® screen Click here for help
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan
Reference: 2,5
Key to terms and symbols Click column headers to sort
Target used in screen: INSRR
Ligand Sp. Type Action Value Parameter
NVP-TAE684 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 8.2 pKd
GSK-1838705A Small molecule or natural product Hs Inhibitor Inhibition 8.1 pKd
foretinib Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 7.3 pKd
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 7.1 pKd
tozasertib Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 6.5 pKd
KW-2449 Small molecule or natural product Hs Inhibitor Inhibition 6.4 pKd
sunitinib Small molecule or natural product Approved drug Ligand has a PDB structure Hs Inhibitor Inhibition 6.4 pKd
crizotinib Small molecule or natural product Approved drug Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 6.2 pKd
JNJ-28312141 Small molecule or natural product Hs Inhibitor Inhibition 5.9 pKd
AST-487 Small molecule or natural product Hs Inhibitor Inhibition 5.8 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen Click here for help
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service.

A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform.

http://www.millipore.com/techpublications/tech1/pf3036
http://www.reactionbiology.com/webapps/main/pages/kinase.aspx

Reference: 1,3
Key to terms and symbols Click column headers to sort
Target used in screen: IRR/IRR(INSRR)
Ligand Sp. Type Action % Activity remaining at 0.5µM % Activity remaining at 1µM % Activity remaining at 10µM
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 1.7 1.5 1.0
indirubin derivative E804 Small molecule or natural product Hs Inhibitor Inhibition 2.8 2.0 2.0
SU11652 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 4.3 13.0 0.0
SB 218078 Small molecule or natural product Hs Inhibitor Inhibition 7.2 74.0 63.0
K-252a Small molecule or natural product Hs Inhibitor Inhibition 14.4 6.0 1.0
isogranulatimide Small molecule or natural product Hs Inhibitor Inhibition 20.7 5.0 3.0
GSK-3 inhibitor XIII Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 20.7 8.0 1.0
sunitinib Small molecule or natural product Approved drug Ligand has a PDB structure Hs Inhibitor Inhibition 21.7
indirubin-3'-monoxime Small molecule or natural product Hs Inhibitor Inhibition 35.7 2.0 1.0
bosutinib Small molecule or natural product Approved drug Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 36.9
Displaying the top 10 most potent ligands  View all ligands in screen »

References

Show »

1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]

2. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]

3. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013) A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. Biochem J, 451 (2): 313-28. [PMID:23398362]

4. Mulvihill MJ, Cooke A, Rosenfeld-Franklin M, Buck E, Foreman K, Landfair D, O'Connor M, Pirritt C, Sun Y, Yao Y et al.. (2009) Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor. Future Med Chem, 1 (6): 1153-71. [PMID:21425998]

5. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]

How to cite this page

Type II RTKs: Insulin receptor family: Insulin receptor-related receptor. Last modified on 13/05/2014. Accessed on 24/01/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=1802.